131 related articles for article (PubMed ID: 3038715)
1. [Centrally and peripherally induced anorectic actions of salmon calcitonin (sCT) in rats: separation of its novel derivative [Gly8]-sCT].
Nakamuta H; Koida M; Ogawa Y; Orlowski RC
Nihon Yakurigaku Zasshi; 1987 Apr; 89(4):191-5. PubMed ID: 3038715
[TBL] [Abstract][Full Text] [Related]
2. Intracerebroventricular injection of 125I-salmon calcitonin in rats: fate, anorexia and hypocalcemia.
Morimoto T; Okamoto M; Koida M; Nakamuta H; Stahl GL; Orlowski RC
Jpn J Pharmacol; 1985 Jan; 37(1):21-9. PubMed ID: 3990041
[TBL] [Abstract][Full Text] [Related]
3. Amylin receptors mediate the anorectic action of salmon calcitonin (sCT).
Lutz TA; Tschudy S; Rushing PA; Scharrer E
Peptides; 2000 Feb; 21(2):233-8. PubMed ID: 10764950
[TBL] [Abstract][Full Text] [Related]
4. Induction of hypocalcemia by intracerebroventricular injection of calcitonin: evidence for control of blood calcium by the nervous system.
Goltzman D; Tannenbaum GS
Brain Res; 1987 Jul; 416(1):1-6. PubMed ID: 3620946
[TBL] [Abstract][Full Text] [Related]
5. Calcitonin-induced anorexia in rats: a structure-activity study by intraventricular injections.
Yamamoto Y; Nakamuta H; Koida M; Seyler JK; Orlowski RC
Jpn J Pharmacol; 1982 Dec; 32(6):1013-7. PubMed ID: 7161957
[TBL] [Abstract][Full Text] [Related]
6. Relationships between hypocalcaemic and anorectic effect of calcitonin in the rat.
Gaggi R; Beltrandi E; Dall'Olio R; Ferri S
Pharmacol Res Commun; 1985 Mar; 17(3):209-15. PubMed ID: 4011645
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic evaluation of the calcitonin analogue SB 205614 in models of osteoclastic bone resorption in vitro and in vivo: comparison with salmon calcitonin and elcatonin.
McSheehy PM; Farina C; Airaghi R; Allievi E; Banfi S; Bertolini D; Ferni G; Frattola D; Oneta S; Pinza M
Bone; 1995 Apr; 16(4):435-44. PubMed ID: 7605704
[TBL] [Abstract][Full Text] [Related]
8. Evidence for calcitonin receptor heterogeneity: binding studies with nonhelical analogs.
Nakamuta H; Orlowski RC; Epand RM
Endocrinology; 1990 Jul; 127(1):163-9. PubMed ID: 2163309
[TBL] [Abstract][Full Text] [Related]
9. Specific inhibition of basal gastric acid secretion by salmon calcitonin in rats does not necessarily involve a central pathway.
Guidobono F; Netti C; Pecile A; Zanelli JM; Gaines-Das RE
Pharmacol Res; 1990; 22(3):287-95. PubMed ID: 1973287
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of rat kidney calcitonin receptors by salmon calcitonin infusion evidenced by autoradiography.
Bouizar Z; Rostène WH; Milhaud G
Proc Natl Acad Sci U S A; 1987 Aug; 84(15):5125-8. PubMed ID: 3037535
[TBL] [Abstract][Full Text] [Related]
11. Divergent structural requirements exist for calcitonin receptor binding specificity and adenylate cyclase activation.
Houssami S; Findlay DM; Brady CL; Martin TJ; Epand RM; Moore EE; Murayama E; Tamura T; Orlowski RC; Sexton PM
Mol Pharmacol; 1995 Apr; 47(4):798-809. PubMed ID: 7723741
[TBL] [Abstract][Full Text] [Related]
12. Oral salmon calcitonin enhances insulin action and glucose metabolism in diet-induced obese streptozotocin-diabetic rats.
Feigh M; Hjuler ST; Andreassen KV; Gydesen S; Ottosen I; Henriksen JE; Beck-Nielsen H; Christiansen C; Karsdal MA; Henriksen K
Eur J Pharmacol; 2014 Aug; 737():91-6. PubMed ID: 24858364
[TBL] [Abstract][Full Text] [Related]
13. A noncyclical analog of salmon calcitonin (N alpha-propionyl Di-Ala1,7,des-Leu19 sCT) retains full potency without inducing anorexia in rats.
Yates AJ; Gutierrez GE; Garrett IR; Mencel JJ; Nuss GW; Schreiber AB; Mundy GR
Endocrinology; 1990 Jun; 126(6):2845-9. PubMed ID: 2351097
[TBL] [Abstract][Full Text] [Related]
14. Calcitonin depresses amphetamine-induced locomotor activity.
Twery MJ; Cooper CW; Mailman RB
Pharmacol Biochem Behav; 1983 Jun; 18(6):857-62. PubMed ID: 6889413
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of calcitonin-induced growth hormone (GH) suppression: roles of somatostatin and GH-releasing factor.
Lengyel AM; Tannenbaum GS
Endocrinology; 1987 Apr; 120(4):1377-83. PubMed ID: 2881773
[TBL] [Abstract][Full Text] [Related]
16. Lipeo-sCT: a novel reversible lipidized salmon calcitonin derivative, its biophysical properties and hypocalcemic activity.
Cheng W; Lim LY
Eur J Pharm Sci; 2009 May; 37(2):151-9. PubMed ID: 19429422
[TBL] [Abstract][Full Text] [Related]
17. Distribution of intraventricular salmon calcitonin and suppression of gastric secretion.
Sabbatini F; Fimmel CJ; Pace F; Tobler PH; Hinder RA; Blum AL; Fischer JA
Digestion; 1985; 32(4):273-81. PubMed ID: 3934017
[TBL] [Abstract][Full Text] [Related]
18. Salmon calcitonin induced head twitch in the rat.
Gaggi R; De Iasio R
Jpn J Pharmacol; 1988 May; 47(1):87-90. PubMed ID: 2457726
[TBL] [Abstract][Full Text] [Related]
19. Conformational flexibility and biological activity of salmon calcitonin.
Epand RM; Epand RF; Orlowski RC; Seyler JK; Colescott RL
Biochemistry; 1986 Apr; 25(8):1964-8. PubMed ID: 3707923
[TBL] [Abstract][Full Text] [Related]
20. Comparison of reversible and nonreversible aqueous-soluble lipidized conjugates of salmon calcitonin.
Cheng W; Lim LY
Mol Pharm; 2008; 5(4):610-21. PubMed ID: 18481870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
